Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

MTS reported for 2024 by RAS

18:27 MTSS

Shareholders of LSR Group approved dividends for 2024

18:10 LSRG

Shareholders of Avangard Bank approved dividends for 2024

16:46 AVAN

Mosenergo reported for 2024 by RAS

16:10 MSNG

Etalon Group received Cyprus redomiciliation authorization

14:27 ETLN

Chizhik's opened its 2,500th store

13:40 X5

LSR will build premium housing on the site of the former Liviz distillery

12:01 LSRG

MTS started an experiment of selling cars in communication salons

10:26 MTSS

Element Group agreed to cooperate with ZNTC for microelectronics production

08:59 ELMT

Sistema reported for 2024 by IFRS

Yesterday at 20:09 AFKS